Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,993 | 582 | 98.0% |
| Education | $199.82 | 11 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,144 | 65 | $0 (2024) |
| Novo Nordisk Inc | $1,111 | 73 | $0 (2024) |
| Gilead Sciences, Inc. | $1,005 | 41 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $932.77 | 51 | $0 (2024) |
| Amgen Inc. | $768.89 | 42 | $0 (2024) |
| PFIZER INC. | $635.11 | 44 | $0 (2024) |
| Lilly USA, LLC | $589.17 | 37 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $490.46 | 35 | $0 (2022) |
| GlaxoSmithKline, LLC. | $490.19 | 28 | $0 (2024) |
| Astellas Pharma US Inc | $484.75 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,205 | 67 | AstraZeneca Pharmaceuticals LP ($192.53) |
| 2023 | $1,335 | 58 | Gilead Sciences, Inc. ($141.55) |
| 2022 | $1,191 | 60 | Gilead Sciences, Inc. ($243.96) |
| 2021 | $1,129 | 61 | Gilead Sciences, Inc. ($154.06) |
| 2020 | $326.67 | 19 | Boehringer Ingelheim Pharmaceuticals, Inc. ($72.00) |
| 2019 | $1,561 | 99 | AstraZeneca Pharmaceuticals LP ($270.06) |
| 2018 | $1,613 | 102 | AstraZeneca Pharmaceuticals LP ($263.70) |
| 2017 | $1,833 | 127 | Novo Nordisk Inc ($238.26) |
All Payment Transactions
593 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Respiratory | ||||||
| 12/19/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.28 | General |
| 12/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: UROLOGY | ||||||
| 12/05/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $1.25 | General |
| Category: UROLOGY | ||||||
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: DIABETES | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Diabetes Care | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2024 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: VACCINES | ||||||
| 10/22/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: UROLOGY | ||||||
| 10/22/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $1.44 | General |
| Category: UROLOGY | ||||||
| 10/22/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $0.60 | General |
| Category: UROLOGY | ||||||
| 10/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $27.86 | General |
| Category: Diabetes | ||||||
| 09/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $3.21 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $31.71 | General |
| 08/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: DIABETES | ||||||
| 08/29/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: UROLOGY | ||||||
| 08/29/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $7.24 | General |
| Category: UROLOGY | ||||||
| 08/27/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: UROLOGY | ||||||
| 08/27/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $1.67 | General |
| Category: UROLOGY | ||||||
| 08/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: Respiratory | ||||||
| 08/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,910 | 3,200 | $511,309 | $260,940 |
| 2022 | 16 | 2,449 | 5,705 | $582,185 | $318,888 |
| 2021 | 18 | 2,305 | 6,105 | $553,552 | $323,424 |
| 2020 | 16 | 2,328 | 5,473 | $613,411 | $301,680 |
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 527 | 1,423 | $284,600 | $134,546 | 47.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 323 | 704 | $112,620 | $48,462 | 43.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 216 | 216 | $43,200 | $31,769 | 73.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 175 | 175 | $14,875 | $12,588 | 84.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 176 | 176 | $7,040 | $6,095 | 86.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 29 | 32 | $8,800 | $5,976 | 67.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 275 | 275 | $9,625 | $5,932 | 61.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 24 | 24 | $5,520 | $4,495 | 81.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 29 | $7,250 | $3,891 | 53.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $8,525 | $2,849 | 33.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $3,000 | $2,253 | 75.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 22 | 23 | $2,254 | $1,103 | 48.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 77 | 80 | $4,000 | $981.58 | 24.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 557 | 1,435 | $217,320 | $96,335 | 44.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 507 | 907 | $166,855 | $85,034 | 51.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 312 | 312 | $59,900 | $47,453 | 79.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 22 | 1,980 | $49,500 | $33,669 | 68.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 176 | 176 | $13,910 | $12,063 | 86.7% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 43 | 52 | $14,300 | $10,061 | 70.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 401 | 401 | $14,200 | $8,855 | 62.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 176 | 176 | $7,040 | $6,098 | 86.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 30 | $7,500 | $4,997 | 66.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 22 | 22 | $4,980 | $4,266 | 85.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 20 | 20 | $4,670 | $3,893 | 83.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 48 | 48 | $13,200 | $3,332 | 25.2% |
About Dr. Michael Kim, MD
Dr. Michael Kim, MD is a Family Medicine healthcare provider based in Fairfax, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144291097.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Kim, MD has received a total of $10,193 in payments from pharmaceutical and medical device companies, with $1,205 received in 2024. These payments were reported across 593 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($9,993).
As a Medicare-enrolled provider, Kim has provided services to 8,992 Medicare beneficiaries, totaling 20,483 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Fairfax, VA
- Active Since 01/30/2006
- Last Updated 08/16/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1144291097
Products in Payments
- FARXIGA (Drug) $787.08
- JARDIANCE (Drug) $657.83
- Ozempic (Drug) $386.74
- Prolia (Biological) $368.16
- Victoza (Drug) $362.71
- JANUVIA (Drug) $339.51
- TRADJENTA (Drug) $313.07
- TRULICITY (Drug) $281.54
- GEMTESA (Drug) $276.45
- XARELTO (Drug) $271.46
- TRELEGY ELLIPTA (Drug) $256.59
- Vascepa (Drug) $253.81
- Rybelsus (Drug) $215.63
- INVOKANA (Drug) $212.98
- MYRBETRIQ (Drug) $203.46
- PREVNAR 20 (Biological) $171.41
- EVENITY (Biological) $160.21
- ELIQUIS (Drug) $157.85
- BREZTRI (Drug) $131.59
- TOUJEO (Drug) $125.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Fairfax
Dr. Shabnam Sachdeva, M.d, M.D
Family Medicine — Payments: $18,322
Dr. Kavian Milani, M.d, M.D
Family Medicine — Payments: $15,958
Dr. Jasmine Moghissi, M.d, M.D
Family Medicine — Payments: $9,595
Mrs. Starla Allen, D.o, D.O
Family Medicine — Payments: $6,467
Carrington Koebele, M.d, M.D
Family Medicine — Payments: $5,638
Dr. Francis O'connor, Md, MD
Family Medicine — Payments: $2,756